Frederik Roels

3.1k total citations
15 papers, 1.1k citations indexed

About

Frederik Roels is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Frederik Roels has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Frederik Roels's work include Neuroblastoma Research and Treatments (9 papers), Signaling Pathways in Disease (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Frederik Roels is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Signaling Pathways in Disease (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Frederik Roels collaborates with scholars based in Germany, United States and United Kingdom. Frederik Roels's co-authors include Matthias Fischer, Lukas Rycak, Martin Eilers, Frank Berthold, Hedwig E. Deubzer, Barbara Hero, Jessica Theißen, Susanne Walz, Jennifer P. Morton and Hélène Dumay‐Odelot and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Frederik Roels

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederik Roels Germany 10 771 394 326 251 115 15 1.1k
Bernd Berwanger Germany 8 755 1.0× 459 1.2× 365 1.1× 222 0.9× 181 1.6× 10 990
Greg Riggins United States 5 692 0.9× 143 0.4× 242 0.7× 237 0.9× 48 0.4× 5 1.0k
Siv Beckman Sweden 11 473 0.6× 291 0.7× 486 1.5× 199 0.8× 61 0.5× 11 833
Danny A. Zwijnenburg Netherlands 17 641 0.8× 337 0.9× 303 0.9× 234 0.9× 67 0.6× 23 965
Bryan W. Johnson United States 8 738 1.0× 193 0.5× 108 0.3× 326 1.3× 102 0.9× 15 1.1k
Marco Lodrini Germany 16 885 1.1× 219 0.6× 178 0.5× 299 1.2× 46 0.4× 24 1.1k
Toshinori Iwahara Japan 7 488 0.6× 194 0.5× 110 0.3× 377 1.5× 73 0.6× 7 1.0k
Markus Bredel United States 15 565 0.7× 192 0.5× 199 0.6× 251 1.0× 46 0.4× 28 914
Walter J. Jessen United States 16 471 0.6× 420 1.1× 77 0.2× 100 0.4× 75 0.7× 20 951
Cihan Cetinkaya Sweden 9 860 1.1× 59 0.1× 143 0.4× 423 1.7× 101 0.9× 10 1.0k

Countries citing papers authored by Frederik Roels

Since Specialization
Citations

This map shows the geographic impact of Frederik Roels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederik Roels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederik Roels more than expected).

Fields of papers citing papers by Frederik Roels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederik Roels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederik Roels. The network helps show where Frederik Roels may publish in the future.

Co-authorship network of co-authors of Frederik Roels

This figure shows the co-authorship network connecting the top 25 collaborators of Frederik Roels. A scholar is included among the top collaborators of Frederik Roels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederik Roels. Frederik Roels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Powers, John T., Kaloyan M. Tsanov, Daniel S. Pearson, et al.. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature. 535(7611). 246–251. 138 indexed citations
2.
Fischer, Matthias, Frederik Roels, Thomas F.E. Barth, et al.. (2016). γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets. Oncotarget. 7(39). 62799–62813. 10 indexed citations
3.
Ikram, Fakhera, Sandra Ackermann, Yvonne Kahlert, et al.. (2015). Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma. Molecular Oncology. 10(2). 344–359. 31 indexed citations
4.
Bae‐Gartz, Inga, Ruth Janoschek, Christina Vohlen, et al.. (2015). Running Exercise in Obese Pregnancies Prevents IL-6 Trans-signaling in Male Offspring. Medicine & Science in Sports & Exercise. 48(5). 829–838. 20 indexed citations
5.
Peifer, Martin, Frederik Roels, Falk Hertwig, et al.. (2015). Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Cancer Research. 75(15_Supplement). LB–210. 1 indexed citations
6.
Ackermann, Sandra, Barbara Hero, Volker Ehemann, et al.. (2014). FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma. BMC Cancer. 14(1). 840–840. 24 indexed citations
7.
Walz, Susanne, Francesca Lorenzin, Jennifer P. Morton, et al.. (2014). Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature. 511(7510). 483–487. 348 indexed citations
8.
Ikram, Fakhera, Sarah E. Ackermann, Frederik Roels, et al.. (2014). 409 Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma. European Journal of Cancer. 50. 130–131. 1 indexed citations
9.
Hertwig, Falk, Fakhera Ikram, Frederik Roels, et al.. (2014). Fibroblast growth factor receptors as therapeutic targets in neuroblastoma. Klinische Pädiatrie. 226(3). 1 indexed citations
10.
Ackermann, Sandra, Barbara Hero, Yvonne Kahlert, et al.. (2013). Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death and Disease. 4(4). e586–e586. 159 indexed citations
11.
Brockmann, Markus, Evon Poon, Anne Carstensen, et al.. (2013). Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma. Cancer Cell. 24(1). 75–89. 223 indexed citations
12.
Decarolis, Boris, Christina Schneider, Barbara Hero, et al.. (2013). Iodine-123 Metaiodobenzylguanidine Scintigraphy Scoring Allows Prediction of Outcome in Patients With Stage 4 Neuroblastoma: Results of the Cologne Interscore Comparison Study. Journal of Clinical Oncology. 31(7). 944–951. 75 indexed citations
13.
Bruns, Ingmar, Akos Czibere, Johannes Fischer, et al.. (2009). The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia. 23(5). 892–899. 61 indexed citations
14.
Bruns, Ingmar, Akos Czibere, Frederik Roels, et al.. (2008). Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.. Blood. 112(11). 3365–3365. 1 indexed citations
15.
Girós, M., et al.. (2003). Síndrome de Zellweger. Presentación de dos nuevos casos. Revista de Neurología. 36(11). 1030–1030. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026